A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with ⩽30% blasts

Garcia-Manero Guillermo, Sekeres Mikkael A., Egyed Miklós, Breccia Massimo, Graux Carlos, Cavenagh Jamie D., Salman Huda S., Illés Árpád, Fénaux Pierre, DeAngelo Daniel J., Stauder Reinhard, Yee Karen W.L, Zhu Nancy Y., Lee Jae-hoon, Borbényi Zita
2017